Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Debt / DBCV 0.250% 2/0
-
Market price (% of par)
-
91.59%
-
Total 13F principal
-
$388,968,722
-
Principal change
-
+$9,879,921
-
Total reported market value
-
$356,448,686
-
Number of holders
-
55
-
Value change
-
+$9,004,471
-
Number of buys
-
21
-
Number of sells
-
20
Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q2 2019
As of 30 Jun 2019,
TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by
55 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$388,968,722
in principal (par value) of the bond.
The largest 10 bondholders included
Allianz Asset Management GmbH, ADVENT CAPITAL MANAGEMENT /DE/, WELLS FARGO & COMPANY/MN, WESTWOOD HOLDINGS GROUP INC, PRUDENTIAL PLC, Polar Capital LLP, STATE STREET CORP, INCOME RESEARCH & MANAGEMENT, AXA, and Whitebox Advisors LLC.
This page lists
55
institutional bondholders reporting positions
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.